More and more renewable energy, while always a good thing, won't be enough. That's the take-home message from Tesla chief executive Elon Musk when he took the stage in April to unveil Powerwall, a home battery system designed to store and supply solar energy.
Despite a string of unsuccessful attempts, Elon Musk's SpaceX team had been closing in on becoming the first to send a rocket into outer space and return it back to Earth fully intact. Coming up with a rocket that's refuel-able and reusable would significantly reduce the cost of space missions, which average about $1.5 billion (roughly Rs. 9,936 crores) per launch.
The Food and Drug Administration's approval of flibanserin, a pill dubbed as the "female viagra" and championed by its backers as a milestone notch for women's empowerment, came with a fair bit of controversy.
This was supposed to be the year in which the masses would be immersed up to their eyeballs in the world of virtual reality. And it did happen - kind of.
Recent discoveries have shown that diseases and the decline in health that comes with aging aren't as inevitable as once thought. And though the research has yet to turn up anything conclusive - in humans at least - the emerging science of longevity is poised to break new ground in the battle against against father time.
Blood tests have long been one of those universally dreaded things. They hurt and can be especially taxing for the elderly and those whose health had been compromised. That was until it Theranos, a much-hyped biotech start-up, announced what seemed like quantum leap in advancing one of the medical industry's most vital tools.
In retrospect, it would make perfect sense that it would be the year of the hoverboard. In "Back to the Future," the fictional timeline was set in 2015 and Marty McFly had one. Heck, that means everyone else should too.